跳至主要内容
临床试验/IRCT20190305042939N3
IRCT20190305042939N3尚未招募3 期

Evaluation the effect of astaxanthin supplementation on the plasma and cellular levels of magnesium, zinc, copper and selenium in patients with type 2 diabetes treated by metformin

Esfahan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • Patients with type 2 diabetesTreated by metformin
  • Age: 20-60 years

排除标准

  • Patients with type 1 diabetes
  • Pregnant women
  • Women in lactation
  • Taking any anti diabetic drug other than metformin
  • Patients with other endocrine disorders
  • Take any other antioxidant supplement

研究者

相似试验

Evaluating the effect of astaxanthin supplement on... | 临床试验